Can an ectoin inhaler tame mild asthma?

NCT ID NCT01478152

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested an inhaled solution of Ectoin, a natural substance, in 18 adults with mild asthma. The goal was to find a safe dose and see if it reduces airway sensitivity. Participants inhaled different doses over short periods, and results were compared to a placebo. The study was small and short, so more research is needed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Ectoin inhalation solution

What this could lead to

If it works, this could point toward a new inhaled treatment to help control mild asthma symptoms.

What could go wrong

This was a very small, early-phase study with only 18 people, so results may not apply broadly. It also tested each dose for just 5-7 days, so long-term effects are unknown.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Inamed Research GmbH & Co KG

    Gauting, Bavaria, 82131, Germany